Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

KBP BioSciences presents new dipeptidyl peptidase 4 inhibitors

Aug. 5, 2011

NPS Pharmaceuticals and GSK form new calcilytics agreement

Aug. 4, 2011

Zoely is approved in the E.U.

Aug. 4, 2011

Novartis enrolls patients in phase II BPS-804 trials

Aug. 4, 2011

Takeda patents new melanin-concentrating hormone MCH1 receptor antagonists

Aug. 4, 2011

Amarin completes remaining studies of AMR-101 required for NDA

Aug. 3, 2011

Protalix replies to FDA complete response letter for taliglucerase alfa

Aug. 3, 2011

Genzyme seeks approval for mipomersen in Europe

Aug. 3, 2011

Trial measures lorcaserin exposure in human cerebrospinal fluid

Aug. 3, 2011

Piramal Life Sciences claims new diacylglycerol O-acyltransferase inhibitors

Aug. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...